)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
IGC Pharma
IGC Pharma (IGC) investor relations material
IGC Pharma Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary22 Oct, 2026
Executive summary
Annual meeting scheduled for December 2, 2026; proxy voting deadline is December 1, 2026 at 11:59 p.m. ET.
Voting matters and shareholder proposals
Ballot includes Claudia Grimaldi’s election, two incentive-plan amendments, approval of a 5,000,000-share grant, say-on-pay, auditor ratification, and an adjournment proposal.
Incentive-plan amendments would move the annual reserve adjustment date from April 1 to January 1 and raise the reserve percentage from 15% to 20%, both effective January 1, 2027; For votes are recommended.
Approval sought for 5,000,000 common shares to be granted over time to current and new employees, officers, advisors, directors, and consultants, subject to Board- or CEO-set metrics; For vote recommended.
Shareholders are asked to ratify Manohar Chowdhry & Associates for FY ending December 31, 2026, and may vote on adjournment or postponement to allow further proxy solicitation.
Board of directors and corporate governance
Claudia Grimaldi is nominated as a Class A director through the 2029 annual meeting, until a successor is elected and qualified or her earlier death, resignation, or removal; Board recommends For.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from IGC Pharma
- CALMA enrollment is complete as shareholders consider seven Board-backed proposals.IGC
Proxy filing - Q2 2026 net loss widened to $3.0M as CALMA trial neared completion and cash reserves declined.IGCQ2 2026
- IGC-AD1 shows strong interim results for Alzheimer's agitation, targeting a $10B+ market.IGCInvestor presentation
- Net loss widened to $2.4M as R&D and SG&A rose, with cash at $207K and 80% CALMA trial enrollment.IGCQ1 2026
- CALMA trial nears completion and MINT-AD AI platform set for beta launch amid favorable regulations.IGCStatus update
- IGC-AD1 demonstrates strong clinical promise for Alzheimer's agitation, driving major growth potential.IGCInvestor presentation
- AI-driven Alzheimer's drug developer registers 978,235 shares for resale by stockholders.IGCRegistration Filing
- Secondary offering of nearly 1M shares; no proceeds to company; lead drug in Phase 2 trials.IGCRegistration Filing
- Phase II data show rapid efficacy for agitation in Alzheimer's and strong AI-driven pipeline progress.IGCQ4 2025
Next IGC Pharma earnings date
Q3 202616 Nov, 2026
IGC Pharma
Next IGC Pharma earnings date
Q3 202616 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage